TREA

98040253 - EVOMYO

Follow

Information

  • Trademark
  • 98040253
  • Serial Number
    98040253
  • Filing Date
    June 13, 2023
    11 months ago
  • Transaction Date
    May 21, 2024
    10 days ago
  • Status Date
    May 21, 2024
    10 days ago
  • Published for Opposition Date
    May 21, 2024
    10 days ago
  • Location Date
    April 18, 2024
    a month ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CHANG, ELIZABETH YI HS
  • Attorney Name
    Maury M. Tepper, III
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EVOMYO
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Case File Event Statements
  • 1/31/2024 - 4 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/16/2023 - 11 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/17/2023 - 10 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/6/2024 - 3 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/6/2024 - 3 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/6/2024 - 3 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/16/2024 - a month ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/16/2024 - a month ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/16/2024 - a month ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/17/2024 - a month ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/1/2024 - a month ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/21/2024 - 10 days ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/21/2024 - 10 days ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB